Vance Street Capital (Vance Street) is pleased to announce the acquisition of Injectech from The West Group (TWG) and the formation of the VSC Medical Moulding platform. The acquisition of Injectech expands VSC Medical Moulding's single-use fluid management solutions offering in the medical device, life science and bioprocessing markets.  In addition to Injectech, the VSC Medical Moulding platform is comprised of Plastic Design Company (PDC), which was acquired in 2021, and Resenex, which was acquired in 2024.  The acquisition of Injectech represents Vance Street's third acquisition in the medical and life science manufacturing sector in 2025, in addition to Zenith Adhesive Component (ZAC) and MRPC. 

"We are delighted to welcome Injectech to the VSC Medical Moulding family," said Jeff Kyle, CEO of VSC Medical Moulding. "By combining VSC Medical Moulding's precision moulding and in-house tooling capabilities with Injectech's extensive component portfolio of custom and standard fluid management solutions, we are expanding our ability to deliver specialised solutions for our customers across critical medical, life science and bioprocessing applications."

VSC Medical Moulding's fluid management division will now be comprised of Injectech and Resenex, enabling the platform to meet a wider range of fluid management needs for its customers through a broader product and component portfolio, as well as expanded custom component capabilities.  The fluid management segment will continue to focus on serving the medical, life science and bioprocessing markets.

"We are excited about the next chapter of growth and our partnership with VSC Medical Moulding and Vance Street," said Jeff Wicks, CEO of Injectech.  "This combination will accelerate Injectech's growth and product innovation, further enhancing our ability to meet the evolving needs of our customers."

"Injectech strengthens our VSC Medical Moulding platform with deep expertise in precision fluid management and a culture of innovation," added Steve Sandbo, Partner at Vance Street Capital. "Together, we will continue building a leading precision moulding and fluid management platform serving the medical device, life science and bioprocessing industries."